5 Cheap Pharmaceutical Stocks For 2022

3. Leap Therapeutics, Inc. (NASDAQ:LPTX)

Number of Hedge Fund Holders: 21   

Real-Time Share Price as of February 15: $2.24 

Leap Therapeutics, Inc. (NASDAQ:LPTX) is a biopharma firm developing therapies for cancer. There is positive hedge fund sentiment around the company. At the end of the third quarter of 2021, 21 hedge funds in the database of Insider Monkey held stakes worth $115 million in Leap Therapeutics, Inc. (NASDAQ:LPTX), up from 9 the preceding quarter worth $23 million.

On January 31, Leap Therapeutics, Inc. (NASDAQ:LPTX) announced that it had entered into an agreement with Leica Biosystems, a cancer diagnostics firm, to develop a diagnostic that will support clinical development of anticancer therapies through detection of Dickkopf-related protein 1.